Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese

Infection

Volumn 39, Issue 5, 2011, Pages 427-431

  Yang, R ^a   Gui, X ^a   Xiong, Y ^a   Gao, S ^a   Zhang, Y ^a   Deng, L ^a   Liang, K ^a   Yan, Y ^a   Rong, Y ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Advanced liver diseases; HBV; HIV

Indexed keywords

ALANINE AMINOTRANSFERASE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; COINFECTION; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV; HIV INFECTIONS; HUMANS; LAMIVUDINE; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; YOUNG ADULT;

EID: 80755139761     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0145-1     Document Type: Article

References (18)

1. CL Thio EC Seaberg R Skolasky Jr, et al. 2002 HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet 360 1921 1926 12493258 10.1016/S0140-6736(02)11913-1 (Pubitemid 35472132)
2. SE Kellerman DL Hanson AD McNaghten, et al. 2003 Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects J Infect Dis 188 571 577 12898445 10.1086/377135 (Pubitemid 37011810)
3. S Park K Kang J Park, et al. 2004 Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis Korean J Gastroenterol 43 246 251 15100488
4. Rong-Rong Y, Xi-En G, Shi-Cheng G, et al. Interaction of hepatitis B and C viruses in patients infected with HIV. J AIDS 2008;48:491-492.
5. WH Sheng MY Chen SM Hsieh, et al. 2004 Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic Clin Infect Dis 38 1471 1477 15156487 10.1086/420744 (Pubitemid 38668595)
6. JF Colin D Cazals-Hatem MA Loriot, et al. 1999 Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men Hepatology 29 1306 1310 10094979 10.1002/hep.510290447 1:STN:280: DyaK1M7pslWitg%3D%3D (Pubitemid 29168769)
7. M Bonacini S Louie N Bzowej, et al. 2004 Survival in patients with HIV infection and viral hepatitis B or C: a cohort study AIDS 18 2039 2045 15577625 10.1097/00002030-200410210-00008 (Pubitemid 39463357)
8. S Bagaglio G Bianchi A Danise, et al. 2011 Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption Infection 39 121 126 21424854 10.1007/s15010-011-0093-9 1:CAS:528:DC%2BC3MXltFCisL0%3D
9. G Morsica F Ancarani S Bagaglio, et al. 2009 Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features Infection 37 445 449 19669092 10.1007/s15010-008-8194-9 1:STN:280:DC%2BD1MnptVWqtw%3D%3D
10. GV Matthews DA Cooper GJ Dore 2007 Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir Antivir Ther 12 119 122 17503756 1:CAS:528:DC%2BD2sXjs1Gnt7k%3D (Pubitemid 46340434)
11. CS Meade J Wang X Lin, et al. 2010 Stress and coping in HIV-positive former plasma/blood donors in China: a test of cognitive appraisal theory AIDS Behav 14 328 338 19127424 10.1007/s10461-008-9494-x
12. HZ Qian SH Vermund RA Kaslow, et al. 2006 Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China AIDS 20 1429 1435 16791018 10.1097/01.aids.0000233577.33973.fa (Pubitemid 43948250)
13. MG Peters 2009 End-stage liver disease in HIV disease Top HIV Med 17 124 128 19890184
14. P Sellier N Schnepf I Jarrin, et al. 2010 Description of liver disease in a cohort of HIV/HBV coinfected patients J Clin Virol 47 13 17 19897410 10.1016/j.jcv.2009.10.010 1:STN:280:DC%2BC3c7gvF2qtw%3D%3D
15. D Salmon-Ceron C Lewden P Morlat, et al. 2005 Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol J Hepatol 42 799 805 15973779 10.1016/j.jhep.2005.01.022 1:CAS:528:DC%2BD2MXktVGmtrk%3D (Pubitemid 40693195)
16. D Konopnicki A Mocroft S de Wit, et al. 2005 Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the Euro SIDA cohort AIDS 19 593 601 15802978 10.1097/01.aids.0000163936.99401.fe (Pubitemid 40543982)
17. CT Fang PJ Chen MY Chen, et al. 2003 Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection J Hepatol 39 1028 1035 14642622 10.1016/S0168-8278(03)00416-1 1:CAS:528:DC%2BD3sXpt1egtbg%3D (Pubitemid 37523776)
18. M Puoti A Cozzi-Lepri C Arici, et al. 2006 Impact of lamivudine on the risk of liver-related death in 2, 041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis Antivir Ther 11 567 574 16964824 1:CAS:528:DC%2BD28XpslSktLY%3D (Pubitemid 44277421)